Does BROLUCIZUMAB-DBLL Cause Iridocyclitis? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Iridocyclitis have been filed in association with BROLUCIZUMAB-DBLL. This represents 4.4% of all adverse event reports for BROLUCIZUMAB-DBLL.
122
Reports of Iridocyclitis with BROLUCIZUMAB-DBLL
4.4%
of all BROLUCIZUMAB-DBLL reports
0
Deaths
8
Hospitalizations
How Dangerous Is Iridocyclitis From BROLUCIZUMAB-DBLL?
Of the 122 reports, 8 (6.6%) required hospitalization.
Is Iridocyclitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
What Other Drugs Cause Iridocyclitis?
ETANERCEPT (233)
ADALIMUMAB (203)
ZOLEDRONIC ACID (168)
METHOTREXATE (164)
AFLIBERCEPT (115)
FARICIMAB\FARICIMAB-SVOA (91)
SECUKINUMAB (77)
FARICIMAB-SVOA (76)
NIVOLUMAB (66)
RANIBIZUMAB (66)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Iridocyclitis Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM